TVARDI THERAPEUTICS, INC. Available-for-sale Securities
TVARDI THERAPEUTICS, INC. (TVRD) had Available-for-sale Securities of $81.22 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2016-08-04
- 2016-06-30: Available-for-sale Securities $81.22M.
- 2016-03-31: Available-for-sale Securities $88.32M.
- 2015-12-31: Available-for-sale Securities $91.64M.
| Period end | Available-for-sale Securities |
|---|---|
| 2016-06-30 | $81.22M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $88.32M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $91.64M 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |